Spiegel Online manager-magazin.de

Mittwoch, 11. Dezember 2019

Börse

BUSINESS WIRE: Altasciences Welcomes Martin Poirier as Senior Director, Bioanalytical Sciences

12.11.2019, 14:28 Uhr

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

LAVAL, Quebec --(BUSINESS WIRE)-- 12.11.2019 --

Anzeige

Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences' preclinical facility in Seattle, WA. Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects.

Martin's outstanding industry reputation and specialization in the field of immunology, as well as more than ten years of experience managing laboratory sciences and establishing new facilities across North America, align with Altasciences' objective of continually enhancing their full service preclinical and clinical bioanalytical capabilities. He joins the Senior Management team, and takes on responsibilities for the growth and development of Altasciences' preclinical bioanalytical business.

"We are very pleased to welcome Martin to our growing team of experts. His years of experience and breadth of knowledge will be an asset as we develop and enhance our facilities and offerings to fully and effectively support our clients' ever-evolving needs," said Mike Broadhurst, General Manager of Altasciences' Seattle site.

About Altasciences

Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients' projects to help support educated, faster, and more complete early drug development decisions. Altasciences' full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences... helping sponsors get better drugs to the people who need them, faster.

Julie-Ann Cabana
Altasciences
913 304-4505
jcabana@altasciences.com

Weitere Nachrichten

19:00 BUSINESS WIRE: Tilray® erhält zusätzliche GMP-Zertifizierung für den EU Campus und internationale Exporterlaubnis für medizinische Cannabis-Endprodukte
18:57 BUSINESS WIRE: PSE: Sanofi schließt sich Systems-based Pharmaceutics Alliance an
18:54 BUSINESS WIRE: PCI Pharma Services kündigt umfangreiche Investitionen zur Erweiterung der Entwicklungs- und Produktionskapazitäten am britischen Standort Tredegar an
18:51 BUSINESS WIRE: Amylgen und Neuron-Experts geben strategische Partnerschaft bekannt
18:00 BUSINESS WIRE: PTW International kündigt Gründung von Orange Rock Studios an, ihres neuen Zweiges für Produkt- und Spieleentwicklung
15:51 BUSINESS WIRE: GSMA: Mobile Technologien ermöglichen enorme Emissionsminderungen als Antwort auf die Klimaproblematik
15:30 BUSINESS WIRE: Skillsoft und MIT Sloan Management Review entwickeln ein gemeinsames Programm zur Förderung von Führungskräften für die digitale Wirtschaft
15:28 IRW-PRESS: Aurania Resources: Ausübung der Aurania Warrants aus 2017 und 2018 mit Laufzeit Dezember 2019 und erforderliche Schritte zur Ausübung
15:08 IRW-PRESS: EnWave Corporation: EnWave unterzeichnet Gerätekaufvertrag und kommerzielle Lizenzabgabe mit Helius Therapeutics Ltd. in Neuseeland für Cannabistrocknung
15:05 IRW-PRESS: EXMceuticals Inc.: EXMceuticals Inc. informiert über Neuigkeiten aus dem Unternehmen
Anzeige
Anzeige